GenSight Biologics S.A.
GSGTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $2 | $7 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $6 | $4 |
| Total Curr. Assets | $3 | $5 | $13 | $7 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $5 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$1 | $4 | $1 | $1 |
| Total NC Assets | $5 | $5 | $2 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7 | $11 | $15 | $9 |
| Liabilities | – | – | – | – |
| Payables | $10 | $6 | $5 | $6 |
| Short-Term Debt | $14 | $14 | $7 | $17 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $2 |
| Other Curr. Liab. | $2 | $2 | $5 | $0 |
| Total Curr. Liab. | $26 | $23 | $17 | $25 |
| LT Debt | $5 | $5 | $16 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $9 | $10 | $7 | $13 |
| Total NC Liab. | $14 | $15 | $23 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $2 |
| Total Liabilities | $39 | $38 | $40 | $40 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $223 | $197 |
| Common Stock | $3 | $3 | $3 | $2 |
| Retained Earnings | -$7 | -$14 | -$6 | -$26 |
| AOCI | -$236 | -$223 | -$223 | -$197 |
| Other Equity | $208 | $207 | -$22 | -$6 |
| Total Equity | -$32 | -$27 | -$25 | -$31 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9 | $11 | $15 | $9 |
| Net Debt | $19 | $17 | $16 | $16 |